Venezuelan President Nicolas Maduro announced Sunday in a television broadcast that his country will join the Phase III clinical trials of the Cuban vaccine candidates Soberana 02 and Abdala.
Venezuelan President Nicolas Maduro announced Sunday in a television broadcast that his country will join the Phase III clinical trials of the Cuban vaccine candidates Soberana 02 and Abdala.
The third phase of the clinical trials of Abdala Covid-19 vaccine candidate started on Monday in this city and the capital municipalities of Guantanamo and Granma with the injection of the first volunteers.
China and Cuba are developing a vaccine against several SARS-CoV-2 variants. According to the Xinhua news agency, Chinese scientists and Cuban experts of the Center for Genetic Engineering and Biotechnology (CIGB) in Havana are developing the product in a facility opened in the city of Yongzhou, Hunan province (center), for research between both countries.
The Neurology and Neurosurgery Institute of Cuba will start a study, in the next few days, on the neurological manifestations in patients who recovered from Covid-19.
The first baby girl born in Cuba by a caesarean section while her mother was in a critical condition due to complications related to Covid-19, is at home on Saturday with her relatives.
Cuba’s anti-Covid-19 vaccine candidate Soberana 02 (Spanish for ‘sovereign’) is supplementing phase III of its clinical trials in Iran with the arrival of 100,000 doses in that country, BioCubaFarma announced on Friday in this capital.
Cuban President Miguel Diaz-Canel on Wednesday insisted on the protection of children and teenagers against Covid-19, and warned about the sequels of the disease.
Numerous Serbian media today showed Cuba’s progress in developing vaccine candidates against Covid-19 called Soberana 01 and 02, Abdala, Mambisa and Soberana Plus, as well as the ongoing trials.
Cuba seeks to increase the exploitation of hydraulic infrastructure by using efficient irrigation techniques, the Ministry of Agriculture (MINAG) announced on Monday.
Cuba will start administering Nasalferon, a drug produced by the country’s biotechnology industry, to travelers and their relatives in order to prevent the replication of the SARS-CoV-2 coronavirus, and strengthen their immune system.